News
-
-
PRESS RELEASE
Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week
Alyea Therapeutics Corporation to present at RESI JPM IPC and attend Nasdaq Opening Bell Ceremony on January 13, 2025. Developing non-addictive solutions to end opioid crisis -
-
-
-
-
-
PRESS RELEASE
ALT5 Sigma Reports Fiscal Financial Results for Third Quarter 2024
ALT5 Sigma Corporation reports record Q3 revenue of $4.94 million, strong customer onboarding, and plans for additional capabilities. CEO Peter Tassiopoulos shares insights on growth trajectory and separation of biotech business -
-